Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 25Neoplasms 14Colorectal Neoplasms 14Melanoma 12Carcinoma, Renal Cell 11Neoplasm Metastasis 9Solid Tumors 8Carcinoma, Hepatocellular 8Head and Neck Neoplasms 7Urinary Bladder Neoplasms 6Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Ovarian Neoplasms 6Lung Neoplasms 6Carcinoma, Transitional Cell 6Breast Neoplasms 6Uterine Cervical Neoplasms 5Lymphoma 5Kidney Neoplasms 4Endometrial Neoplasms 4Solid Tumor 3Pancreatic Neoplasms 3Lymphoma, Non-Hodgkin 3Advanced Solid Tumors 3Urologic Neoplasms 2Treatment-Refractory Solid Tumors 2Solid Cancers 2Recurrence 2

Interventions

trifluridine tipiracil drug combination 1testosterone 17 beta-cypionate 1atezolizumab 1Testosterone Propionate 1Sunitinib 1Standard of Care 1Practice Guidelines as Topic 1Methyltestosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Urologic Diseases × atezolizumab × Clear all
NCT02543645 2018-04-30

A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer

Celldex Therapeutics

Phase 1 Terminated
18 enrolled
BreastDermatologicGenitourinaryHead & NeckThoracic

Clear-cell metastatic renal cell carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡